For IgG antibodies directed to the SARS-CoV-2 S1 protein, we found an overall trend towards higher IgG antibody levels in patients belonging to a more severe disease category, with a statistically significant difference between patients belonging to the moderate and the asymptomatic/mild subgroup (p = 0.0020) (Fig. 1 b).
← all excerpts
Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort.
1
—
—